These studies contradict our findings in the HNSCC cell lines, so to further validate primary tissue STING expression we used IHC to investigate STING protein expression in oropharyngeal-derived tissue microarrays (TMA) from 170 patients with HPV− and HPV+ HNSCC (Table 1). The gene discussed is STING1; the disease is head and neck squamous cell carcinoma.